Medigus Financial Statements From 2010 to 2024
| MDGSDelisted Stock | USD 1.73 0.01 0.58% |
Check Medigus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medigus' main balance sheet or income statement drivers, such as , as well as many indicators such as . Medigus financial statements analysis is a perfect complement when working with Medigus Valuation or Volatility modules.
Medigus |
Medigus Ltd ADR Company Return On Asset Analysis
Medigus' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medigus Return On Asset | -0.0663 |
Most of Medigus' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medigus Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Medigus Ltd ADR has a Return On Asset of -0.0663. This is 99.24% lower than that of the Health Care Equipment & Supplies sector and 99.63% lower than that of the Health Care industry. The return on asset for all United States stocks is 52.64% lower than that of the firm.
Medigus Ltd ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medigus's current stock value. Our valuation model uses many indicators to compare Medigus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medigus competition to find correlations between indicators driving Medigus's intrinsic value. More Info.Medigus Ltd ADR is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Medigus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Medigus Financial Statements
Medigus shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Medigus investors may analyze each financial statement separately, they are all interrelated. The changes in Medigus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Medigus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Medigus operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |